Futura Medical (LSE:FUM) — Stock Price
Futura Medical (LSE:FUM) is currently trading at GBX0.34 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX0.31 and GBX10.03. This page tracks Futura Medical's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see FUM market cap overview.
Futura Medical (FUM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Futura Medical's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Futura Medical Income Statement — Revenue, Profit & Earnings by Year
Futura Medical's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | GBX1.70 Million | GBX13.93 Million | GBX3.10 Million | GBX0.00 | GBX0.00 |
| Cost of Revenue | GBX578.70K | GBX4.24 Million | GBX1.33 Million | GBX24.73K | GBX19.81K |
| Gross Profit | GBX1.12 Million | GBX9.57 Million | GBX1.77 Million | GBX-24.73K | GBX-19.81K |
| Research & Development | GBX1.61 Million | GBX1.74 Million | GBX2.05 Million | GBX4.13 Million | GBX3.77 Million |
| SG&A | — | GBX6.83 Million | GBX6.69 Million | GBX2.74 Million | GBX2.09 Million |
| Total Operating Expenses | GBX10.08 Million | GBX8.39 Million | GBX8.74 Million | GBX6.87 Million | GBX5.87 Million |
| Operating Income | GBX-8.97 Million | GBX1.18 Million | GBX-6.96 Million | GBX-6.87 Million | GBX-5.87 Million |
| EBITDA | GBX-8.84 Million | GBX1.41 Million | GBX-6.83 Million | GBX-6.85 Million | GBX-5.85 Million |
| EBIT | GBX-8.97 Million | GBX1.29 Million | GBX-6.96 Million | GBX-6.87 Million | GBX-5.87 Million |
| Interest Expense | — | — | — | — | GBX0.00 |
| Income Before Tax | GBX-9.07 Million | GBX1.29 Million | GBX-6.89 Million | GBX-6.87 Million | GBX-5.87 Million |
| Income Tax Expense | — | GBX-2.17K | GBX-379.07K | GBX-1.02 Million | GBX-908.60K |
| Net Income | GBX-9.07 Million | GBX1.29 Million | GBX-6.51 Million | GBX-5.85 Million | GBX-4.96 Million |
Futura Medical Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Futura Medical's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | GBX5.22 Million | GBX13.59 Million | GBX11.82 Million | GBX6.47 Million | GBX11.80 Million |
| Total Current Assets | GBX4.47 Million | GBX9.50 Million | GBX9.33 Million | GBX5.31 Million | GBX11.36 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | GBX1.07 Million | GBX2.45 Million | GBX1.15 Million | GBX1.09 Million | GBX915.86K |
| Inventory | GBX260.00 | GBX455.91K | GBX339.00 | GBX1.00 | — |
| Property, Plant & Equipment | — | — | — | — | GBX442.66K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | GBX2.41 Million | GBX4.63 Million | GBX6.34 Million | GBX1.75 Million | GBX2.08 Million |
| Total Current Liabilities | GBX2.17 Million | GBX3.84 Million | GBX6.34 Million | GBX1.75 Million | GBX2.08 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | GBX-3.40 Million | GBX-6.60 Million | GBX-7.71 Million | GBX-4.03 Million | GBX-10.37 Million |
| Total Stockholder Equity | GBX2.81 Million | GBX8.96 Million | GBX5.48 Million | GBX4.72 Million | GBX9.72 Million |
| Retained Earnings | GBX-71.42 Million | GBX-62.88 Million | GBX-67.35 Million | GBX-63.72 Million | GBX-58.55 Million |
Futura Medical Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Futura Medical generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-5.58 Million | GBX438.41K | GBX570.25K | GBX-5.78 Million | GBX-3.87 Million |
| Capital Expenditures | GBX0.00 | GBX1.73 Million | GBX1.51 Million | GBX740.70K | GBX419.72K |
| Free Cash Flow | GBX-5.58 Million | GBX-1.29 Million | GBX-935.60K | GBX-6.52 Million | GBX-4.29 Million |
| Investing Cash Flow | — | GBX-1.73 Million | GBX-1.43 Million | GBX-740.70K | GBX-419.72K |
| Financing Cash Flow | GBX2.38 Million | GBX170.91K | GBX4.55 Million | GBX169.58K | GBX13.65 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | GBX2.02 Million | GBX2.72 Million | GBX671.85K | GBX181.82K |
| Depreciation | GBX121.99K | GBX121.83K | GBX130.27K | GBX24.73K | GBX19.81K |
| Change in Cash | GBX-3.19 Million | GBX-1.12 Million | GBX3.69 Million | GBX-6.35 Million | GBX9.35 Million |
Futura Medical Earnings History — EPS Actual vs. Analyst Estimates
Track Futura Medical's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 13, 2026 | — | — | — |
| Sep 30, 2025 | -0.02 | 0.00 | — |
| Apr 15, 2025 | 0.00 | 0.00 | — |
| Apr 05, 2023 | 0.00 | 0.00 | — |
| Sep 13, 2022 | -0.01 | — | — |
| Apr 26, 2022 | -0.01 | — | — |
| Sep 29, 2021 | -0.01 | — | — |
| Mar 29, 2021 | -0.01 | 0.00 | — |